NEI Schizophrenia Guideline Summary - Guideline Central

Document Overview

Document Title
Schizophrenia
Authoring Society

Neuroscience Education Institute

Document Publication Date
Jun 1, 2013
Page Last Reviewed/Updated
Feb 13, 2026
Document Type
Guideline
Country of Publication
United States
Full Text Freely Available
Yes
Full Text Guideline
www.cambridge.org/core/journals/cns-spectrums/article/metaguidelines-for-the-management-of-patients-with-schizophrenia/C47CEB6C55423179EE774D7AABEA45CF
Source Citation

CNS Spectrums, 18(3), 150-162. doi:10.1017/S109285291300014X

Document Scope, Criteria, and Use Cases

Document Objectives

It provides a “guideline of guidelines” for the treatment of schizophrenia, or “meta-guidelines,” which not only reconcile the various existing standards but also update them to include the use of several newer agents, most of which were marketed following the publication of existing standards.

Scope
Management, Treatment
Diseases/Conditions (MeSH)

D012559 - Schizophrenia

D012561 - Schizophrenia, Childhood

D014150 - Antipsychotic Agents

Keywords
antipsychotics, schizophrenia
Target Patient Population
Patients with schizophrenia
Health Care Settings
Ambulatory, Hospital, Outpatient
Intended Users
Nurse, Nurse Practitioner, Physician, Physician Assistant
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.